Y. Henrotin (Liège, BE)

University of Liège Motricity Sciences

Presenter Of 1 Presentation

Podium Presentation Osteoarthritis

16.3.2 - Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes

Presentation Number
16.3.2
Presentation Topic
Osteoarthritis
Lecture Time
11:24 - 11:33
Session Type
Free Paper Session
Corresponding Author
Disclosure
No Significant Commercial Relationship

Abstract

Purpose

Syndecans are transmembrane heparan sulfate proteoglycans that regulates cell-matrix interactions. Though their glycosaminoglycan chains, syndecans interact with a variety of extracellular matrix molecules as well as with growth factors and cytokines. They are involved especially in embryonic development, tumorigenesis, and angiogenesis Syndecans are expressed by chondrocytes] but their role in cartilage homeostasis or degradation remain poorly documented. We suspect that syndecan-4 plays a critical role in cartilage degradation during osteoarthritis (OA).The aim of this study was to investigate the expression and localization of syndecan-4 in different OA joint tissues.

Methods and Materials

Syndecan-4 mRNA levels were quantified by RT-PCR in human OA primary cells. Syndecan-4 was localized by immunohistochemistry in knee, hip or shoulder OA bone/cartilage biopsies. Syndecan-4 was quantified by immmunoassay in chondrocytes culture supernatant and cell fraction.

Results

Using immunochemistry, syndecan-4 was observed in chondrocytes clusters in the superficial zone of OA knee, but not in OA hip or shoulder cartilage. No significant difference was detected in syndecan-4 expression level in sclerotic compared to non-sclerotic osteoblasts or in inflamed synoviocytes compared to normal/reactive ones. Differentiated hypertrophic chondrocytes from knee, but not from hip cartilage, expressed more syndecan-4 than non-hypertrophic cells. Using an immunoassay for the extracellular domain of syndecan-4, we found 68% of the syndecan-4 in the culture supernatant of OA chondrocytes culture, suggesting that a large majority of the syndecan-4 is shed and released in the extracellular medium. The shedding rate was not affected by hypertrophic differentiation state of the chondrocytes or their joint origin.

Conclusion

Even if chondrocytes clusters are seen in OA knee, hip and shoulder cartilage and hypertrophic differentiation appears in knee and hip OA articular chondrocytes, syndecan-4 synthesis only increased in knee. These findings suggests the presence of biochemical difference between articular cartilage according to their location and that syndecan-4 could be a biochemical marker specific for knee OA.

Collapse

Moderator Of 1 Session

Plaza B&C Special Session
Session Type
Special Session
Date
08.10.2019
Time
12:15 - 13:15
Location
Plaza B&C

Meeting Participant of

Turner - ICRS Board Room (15) ICRS Committee Meeting

Communication Committee

Lord Byron - ICRS Meeting Room (20) ICRS Committee Meeting

Communication Committee (New Committee19-21)